Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris.
Touitou
E
E
Godin
B
B
Shumilov
M
M
Bishouty
N
N
Ainbinder
D
D
Shouval
R
R
Ingber
A
A
Leibovici
V
V
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000473:pathology; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D020156:Salicylic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index
D000900:Anti-Bacterial Agents; D007641:Keratolytic Agents; D002981:Clindamycin; C007084:clindamycin phosphate; D020156:Salicylic Acid